Objective: Diabetes-related complications are increasing the fatality rate among patients with the disease. Diagnostic criteria for diabetes problems include increased thirst, frequent urination, increased hunger, fatigue, irritability, blurred eyesight, slow- healing wounds, etc. Thus, the purpose of this study was to assess the clinical symptom prevalence in individuals with type 2 diabetes. Methodology: This multicenter, cross-sectional study was conducted at different hospitals using a non-probability sampling technique. The duration of the study was about eight months, from August 1, 2022, to March 31, 2023. The study included 405 type 2 diabetes patients ranging up to 50 years of age and older. Age, gender, socioeconomic status, co- morbidities (such as dyslipidemia, and hypertension), and diabetic symptoms were noted. Demographic characteristics, for instance, gender, concurrent diseases, and clinical signs and symptoms associated with type 2 diabetes, were presented as frequencies and percentages. The means and standard deviations were documented for continuous variables. Results: The study findings showed that 220 (54.3%) of the type 2 diabetes patients were more than 50 years old, and 260 (64.2%) of them were males. Moreover, the mean age of the respondents was 55.23±15.19 years. Around 255 (63.0%) of type 2 diabetes patients urinated three times at night, and 270 (66.7%) had light-colored urine. Similarly, 275 (67.9%) type 2 diabetes patients reported having dry, cracked skin. Approximately, 255 (63.0%) reported having tingling or numbness in hands or feet, 215 (53.1%) reported having burning pain in legs or feet, and 370 (91.4%) reported having muscular pain or cramps in legs or feet. Conclusion: This study concluded that frequent urination, usually three times in night, swelling of the feet and ankles, dry cracked skin, muscular pain or cramps in the legs and feet, fatigue, and mood swings were the most prevalent symptoms reported in individuals with type 2 diabetes. Type 2 diabetes was also more likely to develop in people with concomitant comorbidities such as obesity, hypertension, and dyslipidemia.